# Evaluation of ClearLLab Leukemia and Lymphoma Panels

> **NCT03413644** · — · COMPLETED · sponsor: **Beckman Coulter, Inc.** · enrollment: 482 (actual)

## Conditions studied

- Leukemia-Lymphoma

## Interventions

- **DIAGNOSTIC_TEST:** Flow Cytometry

## Key facts

- **NCT ID:** NCT03413644
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2018-04-27
- **Final completion:** 2018-04-27
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2018-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03413644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03413644, "Evaluation of ClearLLab Leukemia and Lymphoma Panels". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03413644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*